RGS7 and neoplasm: Concordantly, RGS7 rs2502448 was previously found to be associated with the 5-year OS of epithelial ovarian cancer (EOC) patients at early disease stages (log-rank test, P = 0.035) but not at advanced stages, suggesting a potential role of this variant in metastasis regardless of tumour type36.